查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1617202

到 2030 年單側雙埠內視鏡的市場預測：按產品、應用、最終用戶和地區進行的全球分析

Unilateral Biportal Endoscopy Market Forecasts to 2030 - Global Analysis By Product (Reusable and Single-use), Application (Decompression, Deherniation, Spinal Stabilization and Other Applications), End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據Stratistics MRC預測，2024年全球單側雙口內視鏡市場規模將達到9.7716億美元，預測期內複合年成長率為8.0%，預計到2030年將達到15.5062億美元。

脊椎手術是一種複雜的微創手術技術（稱為單側雙光束內視鏡檢查（UBE））的主要應用。高解析度相機和手術器械透過身體同一側的兩個小切口插入，以觀察和治療脊椎疾病。與開放性手術相比，UBE具有許多優點，包括組織損傷少、恢復快、肌肉脫離少。該技術對周圍結構的干擾最小，並且能夠精確地直接進入脊柱，為患者提供了比傳統技術侵入性更小、更有效的選擇，從而導致脊椎融合手術、椎間盤切除術和減壓等手術變得越來越受歡迎。

美國國立衛生美國(NIH) 表示，與傳統的開放式脊椎手術相比，微創脊椎手術（包括單側和雙側內視鏡檢查等技術）可將恢復時間縮短高達50%，並減少手術後疼痛。

門診治療的需求不斷成長

隨著世界各地的醫療保健系統注重降低成本，門診手術變得越來越普遍。此型號非常適合 UBE。因為其微創技術可以縮短住院時間和加快復原時間，使患者更快恢復正常活動。此外，越來越多的保險公司透過承保 UBE 手術來支持這一趨勢，因為他們了解這種手術的效率和成本效益。隨著醫療保健提供者尋求降低手術成本並減輕住院設施的負擔，UBE 在門診手術中的作用預計將會增強。

初始設備成本高

所需技術和設備的高成本是UBE廣泛使用的主要障礙之一。 UBE 手術所需的內視鏡工具、攝影機和先進影像系統的購買和維護成本很高。此外，這些系統需要醫院和診所的大量投資，這可能令人望而卻步，尤其是在中低收入地區。儘管快速復健時間和縮短住院時間有可能節省長期成本，但高昂的初始成本可能會阻止一些醫療保健提供者實施 UBE。

技術開發與機器人技術的融合

UBE 和機器人輔助技術的結合為提高手術控制和精確度提供了巨大的機會。機器人系統和 UBE 的結合可以提高外科醫生在微創手術中的精確度，並進一步改善患者的治療效果。 UBE 還可以透過人工智慧和機器學習的應用來幫助改善手術導引和手術結果。此外，由於這些技術進步，UBE 可能成為複雜手術的首選方法，這可能會推動其在專業醫療設施中的擴張。

與傳統手術技術的競爭

儘管UBE的使用越來越多，但傳統的開放性手術和其他微創手術仍然經常進行。許多外科醫生發現這些試驗和測試的手術更加安全，因為數十年的臨床資料已經證明了它們的安全性和有效性。此外，醫療保健提供者和醫院不願意投資像 UBE 這樣的新技術。由於對傳統技術的持續偏好，UBE 市場可能面臨重大障礙，這可能會阻礙某些地區或專業的採用。

COVID-19 的影響：

單側雙端口內視鏡市場受到 COVID-19 大流行的嚴重影響，導致採用和成長放緩。為了優先考慮與 COVID-19 相關的醫療需求並降低院內傳播的風險，在大流行早期階段推遲或取消了包括 UBE 在內的擇期手術。此外，由於全球供應鏈中斷以及醫療保健資源重新分配給流行病管理，因此獲得 UBE 設備和培訓受到阻礙。然而，隨著醫療保健系統的調整和擇期手術的恢復，UBE 在微創手術中的潛力可能會恢復，特別是在尋求減少術後恢復時間和改善患者預後的市場中引起了人們的關注。

預計可重複使用部分在預測期內將是最大的

預計單側雙邊內視鏡市場將由可重複使用部分主導。醫療保健提供者廣泛採用可重複使用的產品，部分原因是高效的滅菌和消毒程序帶來的高回收率，這導致了它們的優越性。根據感染風險對可重複使用的設備進行分類，可以採用客製化的消毒技術，從而提高有效性和安全性。此外，隨著微創手術變得越來越普遍，可重複使用的細分市場預計將繼續推動市場；然而，對感染控制的日益關注和一次性產品的低維護要求正在推動一次性細分市場的快速成長。

預計門診手術中心領域在預測期內複合年成長率最高

在單側雙門內視鏡市場中，門診手術中心（ASC）領域預計將以最高的複合年成長率成長。這種擴張的關鍵促進因素是專業擁有和營運的 ASC 的增加，以滿足對微創外科手術不斷成長的需求。 ASC 對患者和醫療保健專業人員有許多有吸引力的好處，包括節省成本和簡化當天手術。此外，有利的報銷做法和對縮短住院時間的手術的日益渴望也是促使患者轉向門診治療的因素。

比例最高的地區：

單側雙入口內視鏡市場預計將由北美地區主導。非傳染性疾病的高盛行率、先進的醫療保健系統以及不斷成長的需要微創外科手術的老年人口是促成這一優勢的關鍵因素。有利的報銷政策和對尖端外科技術的日益偏好，使美國成為該市場的主要參與者。此外，由於主要市場參與者的存在和持續的技術進步，北美已成為單側雙門戶內視鏡創新和應用的重要中心，這也對該地區的成長做出了重大貢獻。

複合年成長率最高的地區：

單側雙功能內視鏡市場預計將以亞太地區最高的複合年成長率成長。醫療保健基礎設施的快速改善、市場參與企業增加的投資以及促進創新和新技術採用的寬鬆法律規範是推動這一成長的一些因素。由於醫療專業知識的提高和對微創手術的需求不斷成長，中國和印度等國家正在引領這一勢頭。此外，該地區脊椎疾病的發生率不斷上升，尤其是老年人，也推動了市場的發展，因為醫療專業人員正在尋求有效和高效的治療方法。

免費客製化服務：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場公司的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭標基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 研究資訊來源
    • 主要研究資訊來源
    • 二次研究資訊來源
    • 先決條件

第3章市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • COVID-19 的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章全球單側雙埠內視鏡市場：依產品分類

  • 可重複使用的
  • 一次性的

第6章 全球單側雙埠內視鏡市場：依應用分類

  • 減壓
    • 腰椎中央管狹窄
    • 退化性腰椎脊椎狹窄症
    • 椎管狹窄症
  • 疝氣切除術
  • 脊椎穩定
  • 其他用途

第7章全球單側雙入口內視鏡市場：依最終用戶分類

  • 醫院
  • 門診手術中心
  • 專科診所
  • 其他最終用戶

第8章全球單側雙端口內視鏡市場（按地區）

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東/非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第9章 主要進展

  • 合約、夥伴關係、合作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務拓展
  • 其他關鍵策略

第 10 章 公司概況

  • Stryker Corporation
  • Karl Storz
  • Conmed Corporation
  • Kinetix Lifesciences
  • Richard Wolf
  • Jiangsu Bonss Medical Technology Co. Ltd.
  • Smith & Nephew
  • Maxer Endoscopy GmbH
  • Endovision Co. Ltd.
  • Joimax GmbH
Product Code: SMRC28081

According to Stratistics MRC, the Global Unilateral Biportal Endoscopy Market is accounted for $977.16 million in 2024 and is expected to reach $1550.62 million by 2030 growing at a CAGR of 8.0% during the forecast period. Spinal surgery is the main application for the sophisticated minimally invasive surgical technique known as unilateral biportal endoscopy (UBE). A high-definition camera and surgical tools are inserted through two tiny incisions on the same side of the body in order to view and treat spinal disorders. Compared to open surgery, UBE has a number of benefits, including less tissue damage, quicker recovery, and less muscle dissection. With the least amount of disturbance to the surrounding structures, the technique enables precise, direct access to the spine, it has grown in popularity for procedures like spinal fusion, discectomy, and decompression because it offers patients a less invasive and more efficient option than traditional techniques.

According to the National Institutes of Health (NIH), minimally invasive spine surgery, including techniques like unilateral biportal endoscopy, has been shown to reduce recovery times by up to 50%, minimize postoperative pain by 30-40%, and decrease hospital stays by 20-30% compared to traditional open spine surgery.

Market Dynamics:

Driver:

Growing Need for Outpatient Treatments

Outpatient surgeries are becoming more and more popular as a result of healthcare systems around the world focusing more on cutting costs. This model is ideal for UBE since its minimally invasive technique results in shorter hospital stays and faster recovery times, enabling patients to resume their regular activities more quickly. Additionally, an increasing number of insurers are supporting this trend by covering UBE procedures because they understand how efficient and cost-effective they are. It is anticipated that UBE's role in outpatient surgery will grow as healthcare providers seek to reduce operating expenses and the strain on inpatient facilities.

Restraint:

Expensive initial equipment costs

The high expense of the required technology and equipment is one of the main obstacles to the broad use of UBE. The cost of purchasing and maintaining the endoscopic tools, cameras, and sophisticated imaging systems needed for UBE procedures is high. Furthermore, these systems require large investments from hospitals and clinics, which can be prohibitive, particularly in areas with low and middle incomes. Despite the possible long-term cost savings associated with quicker recovery times and shorter hospital stays, these high upfront costs may prevent some healthcare providers from implementing UBE.

Opportunity:

Technological developments and robotics integration

The combination of UBE and robotic-assisted technologies offers a significant chance to improve surgical control and precision. Combining robotic systems with UBE could further enhance patient outcomes by giving surgeons more accuracy during minimally invasive procedures. UBE may also be useful in enhancing surgical navigation and results through the application of AI and machine learning. Moreover, UBE may become the method of choice for complex surgeries as a result of these technological advancements, which would propel its expansion in specialty medical facilities.

Threat:

Competition from conventional surgical techniques

Traditional open surgeries and other minimally invasive procedures are still frequently employed despite the increasing use of UBE. Many surgeons continue to feel more at ease using these tried-and-true techniques because they have been proven safe and effective by decades of clinical data. Furthermore, healthcare providers and hospitals are reluctant to invest in newer technologies like UBE because they frequently prioritize tried-and-true, affordable treatments. The market for UBE may face serious obstacles as a result of this ingrained preference for conventional techniques, which could impede its adoption in particular areas or specialties.

Covid-19 Impact:

The market for unilateral biportal endoscopy was greatly impacted by the COVID-19 pandemic, which caused a slowdown in adoption and growth. In order to prioritize COVID-19-related healthcare needs and lower the risk of transmission in hospitals, elective surgeries, including those involving UBE, were delayed or cancelled during the early stages of the pandemic. Additionally, the availability of UBE equipment and training was hindered by the disruption of global supply chains and the redirection of healthcare resources towards pandemic management. UBE's potential for minimally invasive surgery, however, attracted renewed attention as healthcare systems adjusted and elective surgeries resumed, especially in markets seeking to shorten recovery times following surgery and enhance patient outcomes.

The Reusable segment is expected to be the largest during the forecast period

The unilateral bilateral endoscopy market is anticipated to be dominated by the reusable segment. Due in large part to their high recoverability rates through efficient sterilization and disinfection procedures, healthcare providers have adopted reusable products widely, which has led to their dominance. The classification of reusable instruments according to the risks of infection enables customized disinfection techniques that improve efficacy and safety. Furthermore, the market is expected to continue to be led by the reusable segment as minimally invasive surgeries gain popularity, but the single-use segment is expected to grow quickly because of growing concerns about infection control and the lower maintenance needs of single-use products.

The Ambulatory Surgery Centers segment is expected to have the highest CAGR during the forecast period

In the unilateral biportal endoscopy market, the ambulatory surgery centers (ASCs) segment is anticipated to grow at the highest CAGR. The rise in professionally owned and operated ASCs, which meet the growing demand for minimally invasive surgical procedures, is the main driver of this expansion. ASCs have a number of benefits that are appealing to patients and healthcare professionals alike, such as cost savings and the ease of same-day surgeries. Moreover, favourable reimbursement practices and a growing desire for procedures that shorten hospital stays are additional factors supporting the move towards outpatient care.

Region with largest share:

The market for unilateral biportal endoscopy is expected to be dominated by the North American region. The high incidence of non-communicable diseases, the sophisticated healthcare system, and the growing geriatric population that demands minimally invasive surgical procedures are all major contributors to this dominance. Due to its advantageous reimbursement policies and growing preference for cutting-edge surgical techniques, the United States in particular is a major player in this market. Additionally, North America is a key hub for unilateral biportal endoscopy innovations and applications due to the presence of major market players and ongoing technological advancements, which also greatly contribute to the region's growth.

Region with highest CAGR:

The unilateral biportal endoscopy market is anticipated to grow at the highest CAGR in the Asia-Pacific region. Rapid improvements in healthcare infrastructure, rising market player investments, and a laxer regulatory framework that promotes innovation and the uptake of new technologies are some of the factors driving this growth. Because of their growing medical expertise and rising demand for minimally invasive surgical procedures, nations like China and India are driving this momentum. Furthermore, the market is driven by the increasing incidence of spinal disorders, especially among the elderly population in this area, as medical professionals look for effective and efficient treatment alternatives.

Key players in the market

Some of the key players in Unilateral Biportal Endoscopy market include Stryker Corporation, Karl Storz, Conmed Corporation, Kinetix Lifesciences, Richard Wolf, Jiangsu Bonss Medical Technology Co. Ltd., Smith & Nephew, Maxer Endoscopy GmbH, Endovision Co. Ltd. and Joimax GmbH.

Key Developments:

In August 2024, Stryker announced a definitive agreement to acquire care.ai, a privately held company specializing in delivering AI-assisted virtual care workflows, smart room technology and ambient intelligence solutions. The acquisition will strengthen Stryker's growing healthcare IT offering and wirelessly connected medical device portfolio.

In June 2024, Karl Storz Endoscopy-America, a subsidiary of medical technology company Karl Storz Se & Co, has agreed to acquire Asensus Surgical. Under the agreement, KARL STORZ will acquire all outstanding shares of Asensus for $0.35 per share in cash.

In February 2024, Smith+Nephew, the global medical technology company, announces an agreement with NAVBIT to exclusively distribute the NAVBIT SPRINT(TM) in Australia. A single-use, sterile navigation system with everything provided in a small carton, NAVBIT SPRINT(TM) is designed to suit busy surgeons - and its convenient product format makes it extremely practical and cost efficient for hospitals and day surgery environments.

Products Covered:

  • Reusable
  • Single-use

Applications Covered:

  • Decompression
  • Deherniation
  • Spinal Stabilization
  • Other Applications

End Users Covered:

  • Hospitals
  • Ambulatory Surgery Centers
  • Specialty Clinics
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Unilateral Biportal Endoscopy Market, By Product

  • 5.1 Introduction
  • 5.2 Reusable
  • 5.3 Single-use

6 Global Unilateral Biportal Endoscopy Market, By Application

  • 6.1 Introduction
  • 6.2 Decompression
    • 6.2.1 Lumbar Central Canal Stenosis
    • 6.2.2 Degenerative Lumbar Canal Stenosis
    • 6.2.3 Lumbar Spinal Stenosis
  • 6.3 Deherniation
  • 6.4 Spinal Stabilization
  • 6.5 Other Applications

7 Global Unilateral Biportal Endoscopy Market, By End User

  • 7.1 Introduction
  • 7.2 Hospitals
  • 7.3 Ambulatory Surgery Centers
  • 7.4 Specialty Clinics
  • 7.5 Other End Users

8 Global Unilateral Biportal Endoscopy Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Stryker Corporation
  • 10.2 Karl Storz
  • 10.3 Conmed Corporation
  • 10.4 Kinetix Lifesciences
  • 10.5 Richard Wolf
  • 10.6 Jiangsu Bonss Medical Technology Co. Ltd.
  • 10.7 Smith & Nephew
  • 10.8 Maxer Endoscopy GmbH
  • 10.9 Endovision Co. Ltd.
  • 10.10 Joimax GmbH

List of Tables

  • Table 1 Global Unilateral Biportal Endoscopy Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Unilateral Biportal Endoscopy Market Outlook, By Product (2022-2030) ($MN)
  • Table 3 Global Unilateral Biportal Endoscopy Market Outlook, By Reusable (2022-2030) ($MN)
  • Table 4 Global Unilateral Biportal Endoscopy Market Outlook, By Single-use (2022-2030) ($MN)
  • Table 5 Global Unilateral Biportal Endoscopy Market Outlook, By Application (2022-2030) ($MN)
  • Table 6 Global Unilateral Biportal Endoscopy Market Outlook, By Decompression (2022-2030) ($MN)
  • Table 7 Global Unilateral Biportal Endoscopy Market Outlook, By Lumbar Central Canal Stenosis (2022-2030) ($MN)
  • Table 8 Global Unilateral Biportal Endoscopy Market Outlook, By Degenerative Lumbar Canal Stenosis (2022-2030) ($MN)
  • Table 9 Global Unilateral Biportal Endoscopy Market Outlook, By Lumbar Spinal Stenosis (2022-2030) ($MN)
  • Table 10 Global Unilateral Biportal Endoscopy Market Outlook, By Deherniation (2022-2030) ($MN)
  • Table 11 Global Unilateral Biportal Endoscopy Market Outlook, By Spinal Stabilization (2022-2030) ($MN)
  • Table 12 Global Unilateral Biportal Endoscopy Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 13 Global Unilateral Biportal Endoscopy Market Outlook, By End User (2022-2030) ($MN)
  • Table 14 Global Unilateral Biportal Endoscopy Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 15 Global Unilateral Biportal Endoscopy Market Outlook, By Ambulatory Surgery Centers (2022-2030) ($MN)
  • Table 16 Global Unilateral Biportal Endoscopy Market Outlook, By Specialty Clinics (2022-2030) ($MN)
  • Table 17 Global Unilateral Biportal Endoscopy Market Outlook, By Other End Users (2022-2030) ($MN)
  • Table 18 North America Unilateral Biportal Endoscopy Market Outlook, By Country (2022-2030) ($MN)
  • Table 19 North America Unilateral Biportal Endoscopy Market Outlook, By Product (2022-2030) ($MN)
  • Table 20 North America Unilateral Biportal Endoscopy Market Outlook, By Reusable (2022-2030) ($MN)
  • Table 21 North America Unilateral Biportal Endoscopy Market Outlook, By Single-use (2022-2030) ($MN)
  • Table 22 North America Unilateral Biportal Endoscopy Market Outlook, By Application (2022-2030) ($MN)
  • Table 23 North America Unilateral Biportal Endoscopy Market Outlook, By Decompression (2022-2030) ($MN)
  • Table 24 North America Unilateral Biportal Endoscopy Market Outlook, By Lumbar Central Canal Stenosis (2022-2030) ($MN)
  • Table 25 North America Unilateral Biportal Endoscopy Market Outlook, By Degenerative Lumbar Canal Stenosis (2022-2030) ($MN)
  • Table 26 North America Unilateral Biportal Endoscopy Market Outlook, By Lumbar Spinal Stenosis (2022-2030) ($MN)
  • Table 27 North America Unilateral Biportal Endoscopy Market Outlook, By Deherniation (2022-2030) ($MN)
  • Table 28 North America Unilateral Biportal Endoscopy Market Outlook, By Spinal Stabilization (2022-2030) ($MN)
  • Table 29 North America Unilateral Biportal Endoscopy Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 30 North America Unilateral Biportal Endoscopy Market Outlook, By End User (2022-2030) ($MN)
  • Table 31 North America Unilateral Biportal Endoscopy Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 32 North America Unilateral Biportal Endoscopy Market Outlook, By Ambulatory Surgery Centers (2022-2030) ($MN)
  • Table 33 North America Unilateral Biportal Endoscopy Market Outlook, By Specialty Clinics (2022-2030) ($MN)
  • Table 34 North America Unilateral Biportal Endoscopy Market Outlook, By Other End Users (2022-2030) ($MN)
  • Table 35 Europe Unilateral Biportal Endoscopy Market Outlook, By Country (2022-2030) ($MN)
  • Table 36 Europe Unilateral Biportal Endoscopy Market Outlook, By Product (2022-2030) ($MN)
  • Table 37 Europe Unilateral Biportal Endoscopy Market Outlook, By Reusable (2022-2030) ($MN)
  • Table 38 Europe Unilateral Biportal Endoscopy Market Outlook, By Single-use (2022-2030) ($MN)
  • Table 39 Europe Unilateral Biportal Endoscopy Market Outlook, By Application (2022-2030) ($MN)
  • Table 40 Europe Unilateral Biportal Endoscopy Market Outlook, By Decompression (2022-2030) ($MN)
  • Table 41 Europe Unilateral Biportal Endoscopy Market Outlook, By Lumbar Central Canal Stenosis (2022-2030) ($MN)
  • Table 42 Europe Unilateral Biportal Endoscopy Market Outlook, By Degenerative Lumbar Canal Stenosis (2022-2030) ($MN)
  • Table 43 Europe Unilateral Biportal Endoscopy Market Outlook, By Lumbar Spinal Stenosis (2022-2030) ($MN)
  • Table 44 Europe Unilateral Biportal Endoscopy Market Outlook, By Deherniation (2022-2030) ($MN)
  • Table 45 Europe Unilateral Biportal Endoscopy Market Outlook, By Spinal Stabilization (2022-2030) ($MN)
  • Table 46 Europe Unilateral Biportal Endoscopy Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 47 Europe Unilateral Biportal Endoscopy Market Outlook, By End User (2022-2030) ($MN)
  • Table 48 Europe Unilateral Biportal Endoscopy Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 49 Europe Unilateral Biportal Endoscopy Market Outlook, By Ambulatory Surgery Centers (2022-2030) ($MN)
  • Table 50 Europe Unilateral Biportal Endoscopy Market Outlook, By Specialty Clinics (2022-2030) ($MN)
  • Table 51 Europe Unilateral Biportal Endoscopy Market Outlook, By Other End Users (2022-2030) ($MN)
  • Table 52 Asia Pacific Unilateral Biportal Endoscopy Market Outlook, By Country (2022-2030) ($MN)
  • Table 53 Asia Pacific Unilateral Biportal Endoscopy Market Outlook, By Product (2022-2030) ($MN)
  • Table 54 Asia Pacific Unilateral Biportal Endoscopy Market Outlook, By Reusable (2022-2030) ($MN)
  • Table 55 Asia Pacific Unilateral Biportal Endoscopy Market Outlook, By Single-use (2022-2030) ($MN)
  • Table 56 Asia Pacific Unilateral Biportal Endoscopy Market Outlook, By Application (2022-2030) ($MN)
  • Table 57 Asia Pacific Unilateral Biportal Endoscopy Market Outlook, By Decompression (2022-2030) ($MN)
  • Table 58 Asia Pacific Unilateral Biportal Endoscopy Market Outlook, By Lumbar Central Canal Stenosis (2022-2030) ($MN)
  • Table 59 Asia Pacific Unilateral Biportal Endoscopy Market Outlook, By Degenerative Lumbar Canal Stenosis (2022-2030) ($MN)
  • Table 60 Asia Pacific Unilateral Biportal Endoscopy Market Outlook, By Lumbar Spinal Stenosis (2022-2030) ($MN)
  • Table 61 Asia Pacific Unilateral Biportal Endoscopy Market Outlook, By Deherniation (2022-2030) ($MN)
  • Table 62 Asia Pacific Unilateral Biportal Endoscopy Market Outlook, By Spinal Stabilization (2022-2030) ($MN)
  • Table 63 Asia Pacific Unilateral Biportal Endoscopy Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 64 Asia Pacific Unilateral Biportal Endoscopy Market Outlook, By End User (2022-2030) ($MN)
  • Table 65 Asia Pacific Unilateral Biportal Endoscopy Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 66 Asia Pacific Unilateral Biportal Endoscopy Market Outlook, By Ambulatory Surgery Centers (2022-2030) ($MN)
  • Table 67 Asia Pacific Unilateral Biportal Endoscopy Market Outlook, By Specialty Clinics (2022-2030) ($MN)
  • Table 68 Asia Pacific Unilateral Biportal Endoscopy Market Outlook, By Other End Users (2022-2030) ($MN)
  • Table 69 South America Unilateral Biportal Endoscopy Market Outlook, By Country (2022-2030) ($MN)
  • Table 70 South America Unilateral Biportal Endoscopy Market Outlook, By Product (2022-2030) ($MN)
  • Table 71 South America Unilateral Biportal Endoscopy Market Outlook, By Reusable (2022-2030) ($MN)
  • Table 72 South America Unilateral Biportal Endoscopy Market Outlook, By Single-use (2022-2030) ($MN)
  • Table 73 South America Unilateral Biportal Endoscopy Market Outlook, By Application (2022-2030) ($MN)
  • Table 74 South America Unilateral Biportal Endoscopy Market Outlook, By Decompression (2022-2030) ($MN)
  • Table 75 South America Unilateral Biportal Endoscopy Market Outlook, By Lumbar Central Canal Stenosis (2022-2030) ($MN)
  • Table 76 South America Unilateral Biportal Endoscopy Market Outlook, By Degenerative Lumbar Canal Stenosis (2022-2030) ($MN)
  • Table 77 South America Unilateral Biportal Endoscopy Market Outlook, By Lumbar Spinal Stenosis (2022-2030) ($MN)
  • Table 78 South America Unilateral Biportal Endoscopy Market Outlook, By Deherniation (2022-2030) ($MN)
  • Table 79 South America Unilateral Biportal Endoscopy Market Outlook, By Spinal Stabilization (2022-2030) ($MN)
  • Table 80 South America Unilateral Biportal Endoscopy Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 81 South America Unilateral Biportal Endoscopy Market Outlook, By End User (2022-2030) ($MN)
  • Table 82 South America Unilateral Biportal Endoscopy Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 83 South America Unilateral Biportal Endoscopy Market Outlook, By Ambulatory Surgery Centers (2022-2030) ($MN)
  • Table 84 South America Unilateral Biportal Endoscopy Market Outlook, By Specialty Clinics (2022-2030) ($MN)
  • Table 85 South America Unilateral Biportal Endoscopy Market Outlook, By Other End Users (2022-2030) ($MN)
  • Table 86 Middle East & Africa Unilateral Biportal Endoscopy Market Outlook, By Country (2022-2030) ($MN)
  • Table 87 Middle East & Africa Unilateral Biportal Endoscopy Market Outlook, By Product (2022-2030) ($MN)
  • Table 88 Middle East & Africa Unilateral Biportal Endoscopy Market Outlook, By Reusable (2022-2030) ($MN)
  • Table 89 Middle East & Africa Unilateral Biportal Endoscopy Market Outlook, By Single-use (2022-2030) ($MN)
  • Table 90 Middle East & Africa Unilateral Biportal Endoscopy Market Outlook, By Application (2022-2030) ($MN)
  • Table 91 Middle East & Africa Unilateral Biportal Endoscopy Market Outlook, By Decompression (2022-2030) ($MN)
  • Table 92 Middle East & Africa Unilateral Biportal Endoscopy Market Outlook, By Lumbar Central Canal Stenosis (2022-2030) ($MN)
  • Table 93 Middle East & Africa Unilateral Biportal Endoscopy Market Outlook, By Degenerative Lumbar Canal Stenosis (2022-2030) ($MN)
  • Table 94 Middle East & Africa Unilateral Biportal Endoscopy Market Outlook, By Lumbar Spinal Stenosis (2022-2030) ($MN)
  • Table 95 Middle East & Africa Unilateral Biportal Endoscopy Market Outlook, By Deherniation (2022-2030) ($MN)
  • Table 96 Middle East & Africa Unilateral Biportal Endoscopy Market Outlook, By Spinal Stabilization (2022-2030) ($MN)
  • Table 97 Middle East & Africa Unilateral Biportal Endoscopy Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 98 Middle East & Africa Unilateral Biportal Endoscopy Market Outlook, By End User (2022-2030) ($MN)
  • Table 99 Middle East & Africa Unilateral Biportal Endoscopy Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 100 Middle East & Africa Unilateral Biportal Endoscopy Market Outlook, By Ambulatory Surgery Centers (2022-2030) ($MN)
  • Table 101 Middle East & Africa Unilateral Biportal Endoscopy Market Outlook, By Specialty Clinics (2022-2030) ($MN)
  • Table 102 Middle East & Africa Unilateral Biportal Endoscopy Market Outlook, By Other End Users (2022-2030) ($MN)